GLG Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
GLG Partners's AMGN Position: Q4 2017 in Review
GLG Partners increased its Amgen (AMGN) stake by 15% in Q4 2017, buying an estimated $372K and bringing the position to 16,500 shares worth $2.87M. The position accounts for 0.13% of the portfolio, ranked #189.
GLG Partners first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $6.43M in Q3 2014. 1,735 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.
- GLG Partners held 16,500 shares of Amgen worth $2.87M as of Q4 2017.
- GLG Partners bought 2,100 Amgen shares in Q4 2017, an estimated $372K.
- Amgen made up 0.13% of GLG Partners's portfolio in Q4 2017, its #189 holding.
- GLG Partners first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
- GLG Partners's Amgen position peaked at $6.43M in Q3 2014.
- 1,735 funds tracked by Wall St. Rank held Amgen as of Q4 2017.
Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.